EUVIMEDEUVIMED entdecken
Crossref

Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study

M Rashedul Hoque iD, Leo Lu, Narsis Daftarian, John M Esdaile, Hui Xie iD, J Antonio Aviña-Zubieta iD

Arthritis & Rheumatology · 2023

DOI: 10.1002/art.42337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von M Rashedul Hoque und 5 weiteren Autor:innen. Beteiligte Einrichtung: Arthritis Research Canada, Vancouver, Canada, and Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada. Hauptthemen laut MEDLINE: Antirheumatic Agents, Atrial Fibrillation, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We assessed the association between hydroxychloroquine (HCQ) initiation and risk of arrhythmia among patients with incident rheumatoid arthritis (RA) or with incident systemic lupus erythematosus (SLE).

Methods

All patients with incident RA or SLE and no arrhythmic events, not receiving antiarrhythmic medications, and not receiving HCQ prior to the index date of disease in British Columbia, Canada, between January 1996 and December 2014 were identified from administrative databases. We identified patients who were dispensed HCQ prescriptions (HCQ initiators) or were not dispensed HCQ prescriptions (HCQ noninitiators) during each study year; groups were matched 1:1 by propensity scores using baseline confounders on demographics, comorbidities, medications, and health care utilization. Outcomes were any new arrhythmias, atrial fibrillation, abnormal electrocardiograms, including long QT syndrome and conduction disorder, and other unspecified arrhythmias during follow‐up. We used cause‐specific Cox proportional hazards models with death as a competing event to assess the association between HCQ initiation and the outcomes.

Results

We identified 11,518 propensity score–matched patients with RA or SLE in each group. Over the mean follow‐up of 8 years, there were 1,610 and 1,646 incident arrhythmias in the HCQ initiator group and the noninitiator group, respectively, with crude incidence rates of arrhythmia of 17.5 and 18.1 in 1,000 persons per year, respectively. The adjusted cause‐specific hazard ratio (cHR) for patients who received HCQ was 0.96 (95% confidence interval [95% CI] 0.89–1.03) compared with HCQ noninitiators, and the cHRs for patients who took HCQ and had arrhythmia subtypes of atrial fibrillation, abnormal electrocardiograms, and other unspecified arrhythmias were 0.93 (95% CI 0.83–1.04), 0.98 (95% CI 0.87–1.11), and 0.95 (95% CI 0.84–1.07), respectively.

Conclusion

Risk of any type of arrhythmia was not increased among new users of HCQ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsAtrial FibrillationLupus Erythematosus, SystemicArthritis, RheumatoidHumansHydroxychloroquineBritish Columbia

Substanzen

HydroxychloroquineAntirheumatic Agents

Autor:innen und Institutionen

  • Arthritis Research Canada, Vancouver, Canada, and Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
  • Arthritis Research Canada, Vancouver, Canada.
  • Arthritis Research Canada, Vancouver, Canada, and Department of Medicine, Division of Rheumatology, University of British Columbia, Vancouver, Canada.

ORCID-Profile: M Rashedul Hoque, Hui Xie, J Antonio Aviña-Zubieta

Förderung

  • CIHR
  • Natural Sciences and Engineering Research Council of Canada
  • Canadian Institutes of Health Research

Zitieren

APA

Hoque, M. R., Lu, L., Daftarian, N., Esdaile, J. M., Xie, H., & Aviña-Zubieta, J. A. (2023). Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis & Rheumatology. https://doi.org/10.1002/art.42337

Vancouver

Hoque MR, Lu L, Daftarian N, Esdaile JM, Xie H, Aviña-Zubieta JA. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis & Rheumatology. 2023. doi:10.1002/art.42337

BibTeX
@article{Hoque2023,
  author = {Hoque, M Rashedul and Lu, Leo and Daftarian, Narsis and Esdaile, John M and Xie, Hui and Aviña-Zubieta, J Antonio},
  title = {Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  doi = {10.1002/art.42337}
}
Kostenlos starten →